Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Adverse effect of ganglionic blockers NEC. Symptom management is used.
CNS stimulant adverse effect, unspecified. Symptom management is used.
Other CNS stimulant adverse effect. Symptom management is used.
Other/unspecified anticonvulsant adverse effect. Symptom management is used.
Poisoning by other autonomic drug, intent unknown. Poison control is used.
Intentional self-poisoning by other autonomic drug. Poison control and psychiatry care are used.
Accidental poisoning by other autonomic nervous system drug. Supportive care is used.
Neuropathic spondylopathy. Treating underlying neuropathy is used.
Other cerebrovascular disorder due to disease classified elsewhere. Treating underlying disease is used.
Cerebral arteritis due to other disease classified elsewhere. Treating underlying disease is used.
Cerebral arteritis due to infectious/parasitic disease classified elsewhere. Treating underlying infection is used.
Cerebral amyloid angiopathy. Supportive care is used.
Acoustic neuritis due to infectious/parasitic disease classified elsewhere. Treating underlying infection is used.
Other specified nervous system disorder due to disease classified elsewhere. Treating underlying disease is used.
Other autonomic nervous system disorder due to disease classified elsewhere. Treating underlying disease is used.
Other specified brain disorder due to disease classified elsewhere. Treating underlying disease is used.
Hydrocephalus due to other disease classified elsewhere. Treating underlying disease is used.
Hydrocephalus due to infectious/parasitic disease classified elsewhere. Treating underlying infection and CSF diversion are used.
Other disease-classified-elsewhere polyneuropathy. Treating underlying disease is used.
Other musculoskeletal polyneuropathy. Treating underlying disease is used.
|